HuBei XingFa Chemical Group Co Ltd
SSE:600141

Watchlist Manager
HuBei XingFa Chemical Group Co Ltd Logo
HuBei XingFa Chemical Group Co Ltd
SSE:600141
Watchlist
Price: 32.47 CNY 2.33% Market Closed
Market Cap: ¥39B

Balance Sheet

Balance Sheet Decomposition
HuBei XingFa Chemical Group Co Ltd

Balance Sheet
HuBei XingFa Chemical Group Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
37
157
171
184
195
206
361
205
149
183
424
1 724
783
1 289
1 194
783
966
1 563
1 187
1 568
3 241
4 637
2 023
1 238
Cash
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3 241
4 637
2 023
1 238
Cash Equivalents
37
157
171
184
195
206
361
205
149
183
424
1 724
783
1 289
1 194
783
966
1 563
1 187
1 568
0
0
0
0
Short-Term Investments
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
2
0
15
0
85
84
69
Total Receivables
111
102
141
132
197
185
149
232
313
438
360
946
1 474
1 507
1 954
2 022
1 581
2 063
2 347
2 520
3 027
1 829
2 913
2 874
Accounts Receivables
58
71
107
91
156
154
130
201
196
275
201
416
559
534
551
664
614
787
954
868
934
928
1 244
1 595
Other Receivables
53
31
34
41
41
31
19
31
117
163
159
530
915
973
1 403
1 358
967
1 276
1 393
1 652
2 093
901
1 669
1 279
Inventory
86
110
75
115
189
144
205
236
358
459
562
885
925
1 081
1 183
984
1 433
1 823
2 110
1 503
2 447
2 521
2 234
3 539
Other Current Assets
8
26
39
122
70
32
25
10
39
148
119
357
199
216
106
76
260
574
871
934
354
199
490
574
Total Current Assets
242
394
427
553
654
567
741
683
857
1 229
1 465
3 912
3 381
4 093
4 437
3 866
4 239
6 025
6 514
6 540
9 069
9 272
7 774
8 295
PP&E Net
445
534
993
1 271
1 495
1 719
1 795
1 929
2 334
4 215
5 662
7 901
9 552
12 157
13 393
13 564
13 859
15 370
16 778
17 910
22 147
26 197
30 449
32 917
PP&E Gross
445
534
993
1 271
1 495
1 719
1 795
1 929
2 334
4 215
5 662
7 901
9 552
12 157
13 393
13 564
13 859
15 370
16 778
17 910
22 147
26 197
30 449
32 917
Accumulated Depreciation
104
124
114
185
240
298
338
377
494
613
791
1 042
1 365
1 790
2 345
2 946
3 576
4 198
5 024
5 696
6 111
7 148
8 937
10 862
Intangible Assets
17
16
36
55
86
179
171
220
289
537
696
1 424
1 445
2 029
2 036
1 975
1 547
1 399
2 030
1 965
2 150
2 457
2 998
3 046
Goodwill
0
0
0
0
0
0
0
0
0
0
0
0
0
879
790
748
760
979
951
807
867
948
1 000
807
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
7
5
3
2
0
0
0
15
15
Long-Term Investments
10
10
11
14
16
38
109
225
370
194
265
413
498
305
532
878
898
1 358
1 562
1 851
2 038
2 146
2 054
1 887
Other Long-Term Assets
0
0
1
1
0
5
4
9
10
16
162
173
201
199
175
342
469
526
415
387
463
610
521
809
Other Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
879
790
748
760
979
951
807
867
948
1 000
807
Total Assets
715
N/A
954
+33%
1 468
+54%
1 894
+29%
2 251
+19%
2 508
+11%
2 821
+12%
3 067
+9%
3 861
+26%
6 192
+60%
8 249
+33%
13 824
+68%
15 077
+9%
19 662
+30%
21 373
+9%
21 381
+0%
21 778
+2%
25 659
+18%
28 253
+10%
29 460
+4%
36 735
+25%
41 630
+13%
44 811
+8%
47 776
+7%
Liabilities
Accounts Payable
24
33
59
51
97
83
66
181
261
352
446
685
1 004
1 582
1 811
1 666
1 835
2 439
2 647
3 033
4 285
4 561
5 957
6 178
Accrued Liabilities
6
6
7
6
7
16
8
26
29
44
49
98
138
191
243
234
209
270
185
351
528
629
655
768
Short-Term Debt
92
208
307
453
642
561
902
435
546
200
491
2 273
3 464
5 277
6 161
4 515
6 156
7 821
7 596
7 717
4 647
2 372
2 295
2 955
Current Portion of Long-Term Debt
3
41
172
80
46
0
40
39
29
375
1 110
1 040
1 249
1 635
1 269
2 854
1 366
2 023
1 919
918
3 203
1 593
1 409
2 289
Other Current Liabilities
45
29
35
82
55
105
104
200
165
163
699
682
732
638
431
593
691
1 179
667
950
1 389
1 500
1 581
1 813
Total Current Liabilities
170
317
581
672
847
765
1 120
881
1 030
1 133
2 794
4 779
6 586
9 322
9 915
9 863
10 257
13 732
13 013
12 969
14 051
10 654
11 897
14 003
Long-Term Debt
127
219
421
715
850
1 090
801
964
1 433
2 896
2 698
3 989
3 639
3 409
4 477
3 776
3 629
2 566
4 556
4 505
5 397
8 141
9 247
9 296
Deferred Income Tax
0
0
0
0
0
0
1
0
0
0
0
0
0
64
57
49
45
61
92
121
229
440
571
630
Minority Interest
15
14
13
13
17
45
38
52
35
277
610
1 121
895
1 175
1 173
765
1 018
921
1 419
1 336
1 550
1 036
1 265
1 419
Other Liabilities
0
0
0
0
16
16
9
18
48
193
248
510
580
786
882
1 044
719
841
1 029
1 069
1 228
1 051
972
965
Total Liabilities
312
N/A
549
+76%
1 015
+85%
1 401
+38%
1 730
+23%
1 916
+11%
1 969
+3%
1 914
-3%
2 545
+33%
4 499
+77%
6 350
+41%
10 398
+64%
11 700
+13%
14 756
+26%
16 503
+12%
15 497
-6%
15 668
+1%
18 121
+16%
20 110
+11%
20 001
-1%
22 455
+12%
21 322
-5%
23 952
+12%
26 313
+10%
Equity
Common Stock
160
160
160
160
160
160
210
252
302
365
365
435
435
531
530
512
501
727
1 028
1 119
1 112
1 112
1 112
1 103
Retained Earnings
70
71
92
122
147
180
231
485
574
718
909
1 122
1 053
1 513
1 474
1 512
1 723
1 952
2 062
2 579
6 575
11 887
12 382
13 342
Additional Paid In Capital
173
173
201
213
216
252
410
416
439
609
625
1 868
1 888
2 862
2 865
2 856
2 887
3 854
5 133
5 869
6 662
7 179
7 402
6 818
Unrealized Security Profit/Loss
0
0
0
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
88
105
57
30
203
0
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
1 003
999
1 005
8
4
12
160
167
200
Total Equity
403
N/A
405
+0%
453
+12%
493
+9%
521
+6%
592
+14%
851
+44%
1 153
+35%
1 315
+14%
1 692
+29%
1 899
+12%
3 426
+80%
3 376
-1%
4 906
+45%
4 870
-1%
5 884
+21%
6 110
+4%
7 539
+23%
8 143
+8%
9 459
+16%
14 280
+51%
20 308
+42%
20 859
+3%
21 463
+3%
Total Liabilities & Equity
715
N/A
954
+33%
1 468
+54%
1 894
+29%
2 251
+19%
2 508
+11%
2 821
+12%
3 067
+9%
3 861
+26%
6 192
+60%
8 249
+33%
13 824
+68%
15 077
+9%
19 662
+30%
21 373
+9%
21 381
+0%
21 778
+2%
25 659
+18%
28 253
+10%
29 460
+4%
36 735
+25%
41 630
+13%
44 811
+8%
47 776
+7%
Shares Outstanding
Common Shares Outstanding
318
318
318
318
318
318
417
417
417
439
439
439
522
637
636
615
601
727
1 013
1 101
1 101
1 101
1 093
1 103
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett